StockNews.AI
LMAT
StockNews.AI
8 hrs

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

1. LeMaitre will release Q3 2025 financial results on November 6. 2. A conference call will follow to discuss results and outlook. 3. The company addresses needs of over 200 million with vascular diseases.

Earnings
0%Current Return
VS
0%S&P 500
$87.3210/09 05:55 PM EDTEvent Start
$87.3210/10 01:28 AM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

LeMaitre's consistent performance and upcoming results may attract investor interest. Previous earnings calls have often led to positive stock movement.

How important is it?

Earnings reports are critical for growth companies like LeMaitre. Positive results could significantly boost investor confidence.

Why Short Term?

The immediate upcoming earnings report may influence short-term stock volatility. Earnings announcements often have a significant effect on stock prices.

Related Companies

MDTBSXSYK
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

Related News